
The adoption of a standardized nuclear segmentation pipeline across spatial imaging studies marks a significant advancement in cancer diagnostics. Recent integrations of HOC-FD and CmTSA technologies have confirmed that machine-driven cell segmentation aligns with true biological boundaries, bolstering the reliability of diagnostics in tumor microenvironments. As these methodologies are standardized and calibrated, they promise improved precision in identifying molecular and spatial heterogeneity, paving the way for enhanced patient-specific treatment strategies.